World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
49
Citations
9826
World Ranking
4327
National Ranking
287

Sebastian Kobold publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Sebastian Kobold sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 198 publications — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Sebastian Kobold D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Sebastian Kobold sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 49 D-Index — 13th percentile

13% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Sebastian Kobold is affiliated with Ludwig-Maximilians-Universität München in Germany. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with a strong emphasis on several subfields including Oncology, Immunology, Molecular Biology, Biomedical Engineering, and Genetics.

The main topics covered in their work include:

  • CAR-T cell therapy research
  • Immune Cell Function and Interaction
  • Immunotherapy and Immune Responses
  • Cancer Immunotherapy and Biomarkers
  • Nanowire Synthesis and Applications
  • Monoclonal and Polyclonal Antibodies Research
  • Virus-based gene therapy research

Sebastian Kobold has collaborated frequently with several researchers, including:

  • Adrian Gottschlich (36 joint publications)
  • Stefan Endres (33 joint publications)
  • Florian Märkl (23 joint publications)
  • Sophia Stock (22 joint publications)
  • Marion Subklewe (20 joint publications)

Their publications are present in multiple venues, with a notable number of papers featured in:

  • Blood (12 publications)
  • Poster presentations (11 publications)
  • Frontiers in Immunology (8 publications)
  • Journal for ImmunoTherapy of Cancer (8 publications)
  • Cancer Research (6 publications)

Recent papers authored or co-authored by Sebastian Kobold include:

  • Interleukins in cancer: from biology to therapy (2021, Nature reviews. Cancer)
  • CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment (2021, Cell)
  • Melanoma models for the next generation of therapies (2021, Cancer Cell)
  • Mitochondrial dysfunction promotes the transition of precursor to terminally exhausted T cells through HIF-1α-mediated glycolytic reprogramming (2023, Nature Communications)
  • A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers (2023, Science)

Best Publications

  • Interleukins in cancer: from biology to therapy.

    Daria Briukhovetska;Janina Dörr;Stefan Endres;Peter Libby

  • Advances in cancer immunotherapy 2019 – latest trends

    Stephan Kruger;Stephan Kruger;Matthias Ilmer;Matthias Ilmer;Sebastian Kobold;Bruno L. Cadilha

  • Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells

    Mohamed Reda Benmebarek;Clara Helke Karches;Bruno Loureiro Cadilha;Stefanie Lesch

  • Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity.

    Lucas Ferrari de Andrade;Rong En Tay;Deng Pan;Adrienne M. Luoma

  • Teaching an old dog new tricks: next-generation CAR T cells

    Nicholas Tokarew;Justyna Ogonek;Stefan Endres;Michael von Bergwelt-Baildon

  • CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment.

    Mauro Di Pilato;Mauro Di Pilato;Raphael Kfuri-Rubens;Raphael Kfuri-Rubens;Jasper N. Pruessmann;Aleksandra J. Ozga

  • Melanoma models for the next generation of therapies

    E. Elizabeth Patton;Kristen L. Mueller;David J. Adams;Niroshana Anandasabapathy

  • Epithelial-type systemic breast carcinoma cells with a restricted mesenchymal transition are a major source of metastasis

    Xiao Liu;Junjian Li;Bruno Loureiro Cadilha;Anamarija Markota

  • Inflammation: a common contributor to cancer, aging, and cardiovascular diseases-expanding the concept of cardio-oncology.

    Peter Libby;Sebastian Kobold

  • RIG-I-like helicases induce immunogenic cell death of pancreatic cancer cells and sensitize tumors toward killing by CD8(+) T cells.

    P Duewell;A Steger;H Lohr;H Bourhis

  • Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy

    Stefan Stoiber;Bruno L. Cadilha;Mohamed-Reda Benmebarek;Stefanie Lesch

  • A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers

    Unknown

  • Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CAR.

    Dana Stenger;Tanja A. Stief;Theresa Kaeuferle;Semjon Willier

  • T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours

    Stefanie Lesch;Viktoria Blumenberg;Stefan Stoiber;Adrian Gottschlich

  • Attenuation of peripheral serotonin inhibits tumor growth and enhances immune checkpoint blockade therapy in murine tumor models.

    Marcel André Schneider;Laura Heeb;Michal Mateusz Beffinger;Stanislav Pantelyushin

  • Enhancing tumor T cell infiltration to enable cancer immunotherapy.

    Jin Zhang;Stefan Endres;Sebastian Kobold

  • Toll-Like Receptor 4–Induced IL-22 Accelerates Kidney Regeneration

    Onkar P. Kulkarni;Ingo Hartter;Shrikant R. Mulay;Jan Hagemann

  • Impact of a New Fusion Receptor on PD-1–Mediated Immunosuppression in Adoptive T Cell Therapy

    Sebastian Kobold;Simon Grassmann;Michael Chaloupka;Christopher Lampert

  • Utilizing chemokines in cancer immunotherapy

    Unknown

  • Cancer cells induce interleukin-22 production from memory CD4 + T cells via interleukin-1 to promote tumor growth

    Cornelia Voigt;Peter May;Adrian Gottschlich;Anamarija Markota

  • Bifunctional PD-1 × αCD3 × αCD33 fusion protein reverses adaptive immune escape in acute myeloid leukemia.

    Monika Herrmann;Christina Krupka;Katrin Deiser;Bettina Brauchle

  • Modes of action of TLR7 agonists in cancer therapy.

    Sebastian Kobold;Gabriela Wiedemann;Simon Rothenfußer;Stefan Endres

  • Rationale for Combining Bispecific T Cell Activating Antibodies With Checkpoint Blockade for Cancer Therapy.

    Sebastian Kobold;Stanislav Pantelyushin;Felicitas Rataj;Johannes vom Berg

Frequent Co-Authors

Stefan Endres
Stefan Endres Ludwig-Maximilians-Universität München
Christian Klein
Christian Klein Roche (Switzerland)
Karl-Peter Hopfner
Karl-Peter Hopfner Ludwig-Maximilians-Universität München
Nicolaus Kröger
Nicolaus Kröger Universität Hamburg
Volker Heinemann
Volker Heinemann Ludwig-Maximilians-Universität München
Carsten Bokemeyer
Carsten Bokemeyer Universität Hamburg
Pablo Umana
Pablo Umana California Institute of Technology
Friedrich Haag
Friedrich Haag Universität Hamburg
Klaus-Peter Janssen
Klaus-Peter Janssen Technical University of Munich
Thomas Clavel
Thomas Clavel RWTH Aachen University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring complementary healthcare fields can broaden career opportunities. Many students pursue accelerated nursing paths that build foundational knowledge applicable to immunological research and patient care. Programs like accelerated np programs online offer a fast track into advanced nursing roles, ideal for professionals seeking to integrate clinical expertise with immunology.

Even individuals without prior healthcare experience can transition into nursing through options such as the best online rn programs for non nurses. These programs provide foundational training that aligns well with immunology’s focus on human health and disease.

If you're looking for more accessible entry points, consider the easiest absn program to get into, which helps streamline the Bachelor of Science in Nursing, a solid stepping stone toward immunology-related healthcare roles.

For those seeking quicker credentials, exploring which lpn programs are easiest to get into can provide essential practical experience. Licensed Practical Nurses gain critical exposure to patient care that supports further study or employment in immunology-focused environments.

Best Scientists Citing Sebastian Kobold

Trending Scientists

Recently Published Articles